Literature DB >> 20482558

Impact of body mass index on graft loss in normal and overweight patients: retrospective analysis of 206 renal transplants.

Teresa Papalia1, Rosita Greco, Danilo Lofaro, Simona Maestripieri, Domenico Mancuso, Renzo Bonofiglio.   

Abstract

BACKGROUND: Excess body mass is increasingly prevalent in transplant recipients. Currently, most investigators consider body mass index (BMI) a categorical variable, which assumes that all risk factors and transplant outcomes will be similar in all patients within the same category. We investigated the effect of categorical and continuous BMI increments on renal transplant outcome in normal weight (NW: BMI 18.5-24.9) and overweight (OW: BMI 25-30) patients.
METHODS: We retrospectively studied 206 patients. The mean BMI of our population was 24.3 ± 2.83 kg/m(2) . Patients of each group were similar regarding age, gender, time on dialysis, donor type, cold ischemia time, and number of HLA mismatches. The independent association of BMI with survival was determined using Cox multivariate regression.
RESULTS: OW patients showed a higher prevalence of co-morbidities. In patients with graft loss, there was a higher incidence of delayed graft function, chronic allograft nephropathy, acute rejection, and hypertension. Graft survival was significantly lower in OW patients compared to NW patients upon Kaplan-Meier analysis (p = 0.008). In a multivariate Cox regression analysis, the initial BMI, evaluated as a continuous variable, remained an independent predictor of graft loss (hazard ratio 1.21, 95% CI 1.04-1.47). However, with patient stratification into World Health Organization BMI category and, further, into quartiles of initial BMI, no significant correlation between BMI category and graft loss was found.
CONCLUSION: We suggest that increasing BMI value, although without categorical variation, may represent an independent risk factor for graft loss. Our retrospective analysis of a small sample population will require further studies to confirm these data.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2010        PMID: 20482558     DOI: 10.1111/j.1399-0012.2010.01258.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  9 in total

1.  Influence of the recipient body mass index on the outcomes after kidney transplantation.

Authors:  Juliane Liese; Nils Bottner; Stefan Büttner; Alexander Reinisch; Guido Woeste; Markus Wortmann; Ingeborg A Hauser; Wolf Otto Bechstein; Frank Ulrich
Journal:  Langenbecks Arch Surg       Date:  2017-05-10       Impact factor: 3.445

2.  Leptin deficiency modulates allograft survival by favoring a Th2 and a regulatory immune profile. [corrected].

Authors:  P M M Moraes-Vieira; E J Bassi; R A Larocca; A Castoldi; M Burghos; A P Lepique; F J Quintana; R C Araujo; A S Basso; T B Strom; N O S Câmara
Journal:  Am J Transplant       Date:  2012-09-27       Impact factor: 8.086

3.  Risk factors for graft loss and death among kidney transplant recipients: A competing risk analysis.

Authors:  Jessica Pinto-Ramirez; Andrea Garcia-Lopez; Sergio Salcedo-Herrera; Nasly Patino-Jaramillo; Juan Garcia-Lopez; Jefferson Barbosa-Salinas; Sergio Riveros-Enriquez; Gilma Hernandez-Herrera; Fernando Giron-Luque
Journal:  PLoS One       Date:  2022-07-14       Impact factor: 3.752

4.  Risk Factors for 1-Year Graft Loss After Kidney Transplantation: Systematic Review and Meta-Analysis.

Authors:  Farid Foroutan; Erik Loewen Friesen; Kathryn Elizabeth Clark; Shahrzad Motaghi; Roman Zyla; Yung Lee; Rakhshan Kamran; Emir Ali; Mitch De Snoo; Ani Orchanian-Cheff; Christine Ribic; Darin J Treleaven; Gordon Guyatt; Maureen O Meade
Journal:  Clin J Am Soc Nephrol       Date:  2019-09-20       Impact factor: 8.237

5.  High-Fat Diet-Induced Obesity Enhances Allograft Rejection.

Authors:  Luciana L Molinero; Dengping Yin; Yuk Man Lei; Luqiu Chen; Ying Wang; Anita S Chong; Maria-Luisa Alegre
Journal:  Transplantation       Date:  2016-05       Impact factor: 4.939

Review 6.  Hypertension and obesity after pediatric kidney transplantation: management based on pathophysiology: a mini review.

Authors:  Eunice G John; Liezl T Domingo
Journal:  Int J Prev Med       Date:  2014-03

7.  Predictive value of procalcitonin in chronic allograft dysfunction in kidney transplant recipients.

Authors:  Jing Yao; Lijuan Jiang; Dong Xue; Yanbei Sun
Journal:  Exp Ther Med       Date:  2019-10-21       Impact factor: 2.447

8.  Patients with persistent new-onset diabetes after transplantation have greater weight gain after kidney transplantation.

Authors:  Yoonjung Kim; Jung-Ryul Kim; Heejung Choi; Jung-won Hwang; Hye Ryoun Jang; Jung Eun Lee; Sung-Joo Kim; Yoon-Goo Kim; Dae Joong Kim; Ha Young Oh; Wooseong Huh
Journal:  J Korean Med Sci       Date:  2013-09-25       Impact factor: 2.153

9.  Do we need a different organ allocation system for kidney transplants using donors after circulatory death?

Authors:  Shanka K Benaragama; Teressa Tymkewycz; Biku J John; Andrew Davenport; Ben Lindsey; David Nicol; Jonathon Olsburgh; Martin Drage; Nizam Mamode; Francis Calder; John Taylor; Geoff Koffman; Nicos Kessaris; Mohamed Morsy; Roberto Cacciola; Carmelo Puliatti; Susana Fernadez-Diaz; Asim Syed; Nadey Hakim; Vassilios Papalois; Bimbi S Fernando
Journal:  BMC Nephrol       Date:  2014-05-22       Impact factor: 2.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.